Biocytogen-B (02315) announced interim results: 截至2026年6月30日止六個月的中期業績公告, net profit attributable to owners RMB2.4bn Title: 截至2026年6月30日止六個月的中期業績公告 Revenue: RMB9.4bn Net profit: RMB2.4bn Profit attributable to owners: RMB2.4bn
